Importantly, mice receiving BCG vaccination followed by BAFF or APRIL immunotherapy exhibited superior long-term protection against pulmonary tuberculosis relative to controls that received only BCG. This evidence concerns the gene TNFSF13B and pulmonary tuberculosis.